This inventor holds 5 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: Incyte Corporation, Denovo Biopharma (Hangzhou) Ltd. Co., Denovo Biopharma LLC. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 687 
1 out of 1 
1 out of 6 Years Active: 2010-2022
Title: The Innovations of Wen Luo
Introduction
Wen Luo is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. He holds a total of five patents, showcasing his innovative approach to addressing complex medical challenges. His work primarily focuses on developing methods and compositions that enhance the efficacy of cancer treatments.
Latest Patents
Wen Luo's latest patents include groundbreaking inventions that predict the activity of enzastaurin. This invention describes biomarkers that correlate with individual responses to enzastaurin in treating diseases such as DLBCL, GBM, and other cancer types. The biomarkers can be utilized in companion diagnostic tests to predict drug responses, ensuring that treatments are tailored to benefit those who will respond positively while excluding those who may experience adverse effects. Another notable patent involves methods and compositions for predicting the activity of retinoid X receptor modulators. This invention identifies genomic biomarkers that correlate with responses to therapeutic retinoid X receptor modulators, such as bexarotene, in treating non-small cell lung cancer. These discoveries also aim to improve patient outcomes through personalized medicine.
Career Highlights
Throughout his career, Wen Luo has worked with esteemed companies in the biotechnology sector, including Incyte Corporation and Denovo Biopharma. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.
Collaborations
Wen Luo has collaborated with notable colleagues, including Vicki S. Elliott and Reena Khare. Their combined expertise has fostered an environment of innovation and progress in the development of new therapeutic strategies.
Conclusion
Wen Luo's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in personalized medicine, ultimately improving patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile